This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2016 Jul 30;388(10043):530-2.

doi: 10.1016/S0140-6736(16)00002-7. Epub 2016 Feb 6.

From epidemiological transition to modern cardiovascular epidemiology: hypertension in the 21st century

Jacques Blacher¹, Bernard I Levy², Jean-Jacques Mourad³, Michel E Safar⁴, George Bakris⁵

Affiliations

Affiliations

¹ Diagnosis and Therapeutic Centre, Hôtel-Dieu University Hospital, Assistance Publique-Hôpitaux de Paris, Paris-Descartes University, Paris, France. Electronic address: jacques.blacher@aphp.fr.
² Vessels and Blood Institute, Lariboisière University Hospital, Paris, France; Paris Cardiovascular Research Centre, INSERM U970, Paris, France.
³ Department of Internal Medicine, Avicenne University Hospital, Assistance Publique-Hôpitaux de Paris, University Paris 13, Bobigny, France.
⁴ Diagnosis and Therapeutic Centre, Hôtel-Dieu University Hospital, Assistance Publique-Hôpitaux de Paris, Paris-Descartes University, Paris, France.
⁵ Department of Medicine, American Society of Hypertension Comprehensive Hypertension Center, University of Chicago Medicine, IL, USA.

PMID: 26856636
DOI: 10.1016/S0140-6736(16)00002-7

From epidemiological transition to modern cardiovascular epidemiology: hypertension in the 21st century

Jacques Blacher et al. Lancet. 2016.

. 2016 Jul 30;388(10043):530-2.

doi: 10.1016/S0140-6736(16)00002-7. Epub 2016 Feb 6.

Authors

Jacques Blacher¹, Bernard I Levy², Jean-Jacques Mourad³, Michel E Safar⁴, George Bakris⁵

Affiliations

¹ Diagnosis and Therapeutic Centre, Hôtel-Dieu University Hospital, Assistance Publique-Hôpitaux de Paris, Paris-Descartes University, Paris, France. Electronic address: jacques.blacher@aphp.fr.
² Vessels and Blood Institute, Lariboisière University Hospital, Paris, France; Paris Cardiovascular Research Centre, INSERM U970, Paris, France.
³ Department of Internal Medicine, Avicenne University Hospital, Assistance Publique-Hôpitaux de Paris, University Paris 13, Bobigny, France.
⁴ Diagnosis and Therapeutic Centre, Hôtel-Dieu University Hospital, Assistance Publique-Hôpitaux de Paris, Paris-Descartes University, Paris, France.
⁵ Department of Medicine, American Society of Hypertension Comprehensive Hypertension Center, University of Chicago Medicine, IL, USA.

PMID: 26856636
DOI: 10.1016/S0140-6736(16)00002-7

No abstract available

PubMed Disclaimer

Comment in

Hypertension control and cardiovascular disease.
Messerli FH, Fischer U, Rimoldi SF, Bangalore S. Messerli FH, et al. Lancet. 2017 Jan 14;389(10065):153. doi: 10.1016/S0140-6736(17)30017-X. Epub 2017 Jan 13. Lancet. 2017. PMID: 28102137 No abstract available.
Hypertension control and cardiovascular disease.
James JE. James JE. Lancet. 2017 Jan 14;389(10065):154. doi: 10.1016/S0140-6736(17)30018-1. Epub 2017 Jan 13. Lancet. 2017. PMID: 28102138 No abstract available.

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

Supplementary concepts

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information